Science Alone Won’t Stop Lassa Fever

Three promising Lassa fever vaccine candidates are in clinical development, one of which could be licensed in the next decade. But to ensure a swift and effective rollout, West African countries must start planning now to determine who should receive it, how to deliver it, and how to finance and regulate it.